Chemify alternatives and competitors
The closest alternatives to Chemify are PostEra, Deep Genomics, Superluminal Medicines and Terray Therapeutics.
Chemify makes the molecules it designs, in a laboratory it built itself. Rather than handing a design to somebody with a laboratory, it is trying to turn its own laboratory into a printer.
10 alternatives to Chemify
What each product does, with its price as the vendor publishes it.
-
P
PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to decide what to make, PostEra builds models of how to make it.
Price: No published price
-
D
Deep Genomics is a Toronto AI drug discovery company launched in 2015 by Brendan Frey out of his University of Toronto work on the genetic determinants of disease.
Price: No published price
-
S
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Price: No published price
-
T
Terray Therapeutics is a Los Angeles small molecule company whose founding argument is about data rather than models. Its chief executive Jacob Berlin put it plainly at the Series A: even the most powerful artificial intelligence cannot get past insufficient or unclear data.
Price: Not applicable
-
E
Enveda is a clinical stage biotechnology company in Boulder, Colorado that uses AI to discover medicines from the chemistry of living things.
Price: Not applicable
-
V
Variational AI develops Enki, a generative model for designing small molecules against a research team's target product profile.
Price: Custom project pricing
-
A
Aqemia designs small molecule drug candidates with Qemi, a platform that joins physics based prediction of how tightly a molecule binds its target with generative AI that proposes new molecules.
Price: No published price
-
B
BigHat Biosciences, founded in San Mateo, California in 2019 by Mark DePristo and Peyton Greenside, designs and engineers antibodies with machine learning tied to its own automated laboratory, starting from an existing molecule, its own or a partner's, and improving it in rounds.
Price: No published price
-
C
Cellarity is a Flagship Pioneering company in Somerville, Massachusetts, founded in 2019, that designs drugs against the behavior of a whole cell rather than against a molecular target.
Price: Not applicable
-
L
Lila Sciences makes very large claims about what its platform can do, and as of September 2026 it has begun publishing evidence for some of them.
Price: No published price
Chemify alternatives, answered
What are the best alternatives to Chemify?
The closest alternatives to Chemify are PostEra, Deep Genomics, Superluminal Medicines, Terray Therapeutics and Enveda. PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Deep Genomics is a Toronto AI drug discovery company launched in 2015 by Brendan Frey out of his University of Toronto work on the genetic determinants of disease. Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Who are Chemify's competitors?
Chemify's competitors in the Drug Discovery AI category include PostEra, Deep Genomics, Superluminal Medicines, Terray Therapeutics, Enveda and Variational AI.